Episode Details

Back to Episodes

Isomorphic Labs $2.1 Billion Series B: Sovereign Wealth Bets on DeepMind's Drug Design Engine and the Race to AI Designed Therapeutics - May 17, 2026

Published 1 month, 4 weeks ago
Description
Isomorphic Labs $2.1 Billion Series B: Sovereign Wealth Bets on DeepMind's Drug Design Engine and the Race to AI Designed Therapeutics - May 17, 2026 Demis Hassabis's DeepMind spinout just closed a $2.1 billion Series B led by Thrive Capital with new participation from Temasek, CapitalG, the UK Sovereign AI Fund, and Abu Dhabi's MGX. Rick and Laura unpack what the IsoDDE engine, the Novartis, Eli Lilly, and Johnson & Johnson partnerships, and a Phase one trial target by year end mean for the future of pharma. The conversation also weighs the geopolitical signal of three sovereign wealth funds backing a single biotech in the same round. Hosted by Rick Spair and Laura. The DX Today Podcast brings you daily deep dives into the most consequential stories in the AI ecosystem. Send us fan mail: https://dxtoday.com/contact #AI #AIDrugDiscovery #IsomorphicLabs #DeepMind #BiotechAI
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us